Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data
On track to read out multiple Phase 2 clinical trials in the coming quarters, beginning in Q3 2024Performance benchmarking completed on BioHive-2, Recursion's next generation supercomputer, which will...
For all the high-flying claims for AI in drug discovery, Leash Bio has started with a more grounded approach — literally.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2023 Earnings Call Transcript
Recursion to Host Public L(earnings) Call on February 27
Altitude Lab Startups Raise Over $120M in Capital
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
Recursion Pharma spikes after licensing deal with Bayer
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
Bayer and Recursion focus research collaboration on Oncology